Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | TYMS | P04818 | 1/20 | 0.43 |
| ▸ | IKBKB | O14920 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22517368 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CYP3A4TDP1TSHRMAOA | |
| SCHEMBL30683153 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CYP3A4TDP1TSHRMAOA | |
| SCHEMBL30683143 | 0.85 | ALDH1A1 (0.47) | ALDH1A1CYP3A4TDP1TSHRMAOA | |
| SCHEMBL16135148 | 0.85 | ALDH1A1 (0.47) | ALDH1A1CYP3A4TDP1TSHRMAOA | |
| SCHEMBL22567857 | 0.85 | ALDH1A1 (0.47) | ALDH1A1CYP3A4TDP1TSHRMAOA | |
| SCHEMBL55383 | 0.84 | HSD17B10 (0.46) | ALDH1A1CYP3A4TDP1TSHRMAOA | |
| SCHEMBL20851654 | 0.82 | ALDH1A1 (0.56) | ALDH1A1CYP3A4TDP1MAOAHSD17B10 | |
| SCHEMBL12286029 | 0.80 | HSD17B10 (0.54) | ALDH1A1CYP3A4TDP1MAOAHSD17B10 | |
| SCHEMBL30266735 | 0.80 | MAOA (0.52) | ALDH1A1CYP3A4TDP1MAOAHSD17B10 | |
| SCHEMBL22567844 | 0.80 | ALDH1A1 (0.58) | ALDH1A1CYP3A4TDP1MAOAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11844270-B2 | Compound and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-11844270-B2 | Compound and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-11844270-B2 | Compound and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-20200335698-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | LG DISPLAY CO., LTD. (KR) | 2020-10-22 | — | — | US | disclosed |
| US-20200335698-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | LG DISPLAY CO., LTD. (KR) | 2020-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11844270-B2 | Compound and organic light emitting device including the same | TMEM109, CRY1, VDAC1 | ALDH1A1 54/4885CYP3A4 212/4885TDP1 1190/4885 |
| US-20200335698-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | TMEM109, TRPC1, MAP1LC3B | ALDH1A1 155/4885CYP3A4 436/4885TDP1 1643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.